Publication | Open Access
Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 Trial
19
Citations
33
References
2022
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1